Interazioni tra farmaci
Nivolumab + Rozanolixizumab
Gravità: Moderata
Nivolumab and Rozanolixizumab: moderate interaction.
Ultimo aggiornamento
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
Sintesi
Rozanolixizumab blocks the neonatal Fc receptor, which normally protects IgG antibodies from degradation. Nivolumab is an IgG4 antibody, so its clearance could increase and exposure fall, potentially weakening antitumor effect. The clinical significance is uncertain.
Cosa significa questa interazione in parole semplici
Nivolumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Nivolumab belongs to Oncology; Rozanolixizumab belongs to Miscellaneous.
Perché avviene
Rozanolixizumab blocks FcRn-mediated IgG recycling, which may accelerate catabolism of IgG-based nivolumab.
Cosa fare
Avoid combining where possible, or monitor tumor response closely if rozanolixizumab is necessary. Involve oncology and neurology specialists in weighing alternatives.
Cosa chiedere al farmacista
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Nivolumab e Rozanolixizumab, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Provi Pro+ gratis per 7 giorni sul web. Nessuna carta.
Altre interazioni di Nivolumab
- Nivolumab + Thalidomide Maggiore
- Dexamethasone-tobramycin + Nivolumab Moderata
- Dexamethasone + Nivolumab Moderata
- Efgartigimod / hyaluronidase sc + Nivolumab Moderata
- Efgartigimod alfa + Nivolumab Moderata
- Nivolumab + Ponesimod Moderata
Altre interazioni di Rozanolixizumab
- Rozanolixizumab + Upadacitinib Maggiore
- Abatacept + Rozanolixizumab Moderata
- Adalimumab + Rozanolixizumab Moderata
- Ado-trastuzumab + Rozanolixizumab Moderata
- Basiliximab + Rozanolixizumab Moderata
- Bevacizumab + Rozanolixizumab Moderata
Domande frequenti
Can I take Nivolumab with Rozanolixizumab?
MediHelp rates the interaction as moderate. Nivolumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rozanolixizumab blocks the neonatal Fc receptor, which normally protects IgG antibodies from degradation. Nivolumab is an IgG4 antibody, so its clearance could increase and exposure fall, potentially weakening antitumor effect. The clinical significance is uncertain.
How serious is the interaction between Nivolumab and Rozanolixizumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where possible, or monitor tumor response closely if rozanolixizumab is necessary. Involve oncology and neurology specialists in weighing alternatives.
What other medicines interact with Nivolumab?
MediHelp also lists interactions of Nivolumab with, for example, Thalidomide, Dexamethasone-tobramycin, Dexamethasone. The full list is on the Nivolumab page.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
